Regine Mugeni

Regine Mugeni

Auto-generated profile, based on publicly available information

Regine Mugeni

Kibagabaga District Hospital, Kigali, Rwanda

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
26 April 2022 in BMC Cardiovascular Disorders
Verified
Journal Article
Open access
PDF file
ENEvariste Ntaganda
Evariste Ntaganda
RMRegine Mugeni
Regine Mugeni
EHEmmanuel Harerimana
Emmanuel Harerimana
GNGedeon Ngoga
Gedeon Ngoga
SDSymaque Dusabeyezu
Symaque Dusabeyezu
MTMarc Twagirumukiza
Marc Twagirumukiza
Background: Hypertension remains the major risk factor for cardiovascular diseases (CVDs) worldwide with a prevalence and mortality in low- and middle-income countries (LMICs) among the highest. The early detection of hypertension risk factors is a crucial pillar for CVD prevention. Design and method: This cross-sectional study included 4284 subjects, mean age 46 ± 16SD, 56.4% females and mean BMI 26.6 ± 3.7 SD. Data were collected through a screening campaign in rural area of Kirehe District, Eastern of Rwanda, with the objective to characterize and examine the prevalence of elevated blood pressure (BP) and other CVD risk factors. An adapted tool from the World Health Organization STEPwise Approach was used for data collection. Elevated BP was defined as ≥ 140/90 mm/Hg and elevated blood glucose as blood glucose ≥ 100 mg/dL after a 6-h fast. Results: Of the sampled population, 21.2% (n = 910) had an elevated BP at screening; BP was elevated among individuals not previously known to have HTN in 18.7% (n = 752). Among individuals with a prior diagnosis of HTN, 62.2% (n = 158 of 254) BP was uncontrolled. Age, weight, smoking, alcohol history and waist circumference were associated with BP in both univariate analyses and multivariate analysis. Conclusion: High rates of elevated BP identified through a health screening campaign in this Rwandan district were surprising given the rural characteristics of the district and relatively low population age. These data highlight the need to implement an adequate strategy for the prevention, diagnosis, and control of HTN that includes rural areas of Rwanda as part of a multicomponent strategy for CVD prevention.

25 November 2019 in BMJ Open
Verified
Journal Article
Open access
PDF file
RMRegine Mugeni
Regine Mugeni
ENEugene Nkusi
Eugene Nkusi
EREric Rutaganda
Eric Rutaganda
SMSanctus Musafiri
Sanctus Musafiri
FMFlorence Masaisa
Florence Masaisa
TWTim Walker
Tim Walker
Objectives To determine the prevalence of proximal deep vein thrombosis (DVT) by ultrasound scanning, as well as associated clinical features and known risk factors, among medical and obstetrics–gynaecology inpatients in two Rwandan tertiary hospitals. Design Cross-sectional study. Settings Rwanda teaching hospitals: Kigali and Butare University Teaching Hospitals. Participants 901 adult patients admitted to the Departments of Internal Medicine and Obstetrics–Gynecology (O&G) who were at least 21 years of age and willing to provide a consent. Outcomes Prevalence of proximal DVT, clinical features and known risk factors associated with DVT. Methods Between August 2015 and August 2016, participants were screened for DVT by compressive ultrasound of femoral and popliteal veins, conducted as a monthly cross-sectional survey of all consenting eligible inpatients. Patients completed a self-report survey on DVT risk factors. Prevalence of proximal DVT by compression ultrasonography was the primary endpoint, with univariate and multivariate regression analyses performed to assess associated clinical features and risk factors. Results Proximal DVT was found in 5.5% of the study population, with similar rates in medical and O&G inpatients. The mean age was 41±16 SD (range, 21–91), 70% were female and 7% were pregnant. Univariate analysis showed active malignancy, immobilisation, prolonged recent travel and history of DVT to be significant risk factors for proximal DVT (all p values <0.05); while only active malignancy was an independent risk factor on multivariate regression (OR 5.2; 95% CI 2.0 to 13). Leg pain or tenderness, increased calf circumference, unilateral limb swelling or pitting oedema were predictive clinical features of DVT on both univariate analysis and multivariate regression (all p values <0.05). Conclusion Proximal DVT prevalence is high among hospitalised medical and O&G patients in two tertiary hospitals in Rwanda. For reducing morbidity and mortality, research to develop Africa-specific clinical prediction tools for DVT and interventions to increase thromboprophylaxis use in the region are urgently needed.

3 February 2025 in Journal of Epidemiology and Global Health
Verified
Journal Article
Open access
PDF file
ENEvariste Ntaganda
Evariste Ntaganda
Ziad El-KhatibZiad El-Khatib
Ziad El-Khatib
RMRegine Mugeni
Regine Mugeni
BNBoniface Nsengiyumva
Boniface Nsengiyumva
CMClarisse Musanabaganwa
Clarisse Musanabaganwa
RKRichard Kalisa
Richard Kalisa
Background: Hypertension is a major public health issue and a leading risk factor for cardiovascular disease (CVD). We assessed blood pressure (BP) control among adult hypertensive patients attending non-communicable disease (NCD) clinics in five Rwandan district hospitals. Methods: We extracted data on hypertensive management from five Rwandan district hospitals from June 2016 to August 2021. BP control was defined as systolic blood pressure (SBP) < 140 mmHg and diastolic blood pressure (DBP) < 90 mmHg measured within the last four months. We performed statistical analysis using chi-square tests and multivariate regression analyses with 95% confidence intervals (CI). Results: Blood pressure control was achieved in 41.5% of hypertensive patients (n = 438/1,055). The majority were aged > 60 years (mean age 62; n = 663/1,055; 62.8%), and women, with approximately three-quarters of patients (n = 796/1,055; 75.5%) had a BMI between 18.5 and 24.9 Kg/m2 and the majority (n = 843/1,055; 79.9%) resided in rural districts. More than half (n = 585/1,055; 55.5%) were taking two antihypertensive medications. Factors significantly associated with uncontrolled BP included BMI ≥ 30 kg/m2 (p < 0.001), use of Angiotensin-converting enzyme (ACE) inhibitors (p = 0.01), use of four antihypertensive drugs (p = 0.013), and missing an NCD clinic appointment (p < 0.001). Conclusions: BP control rates among hypertensive patients attending NCD clinics remain low. Strengthening patient counseling, encouraging physical activity, and improving medication adherence are critical. Building the capacity of healthcare staff at both hospital and health centre levels is vital to improving hypertension management in NCD clinics.

24 July 2024 in BMJ Open
Verified
Journal Article
Open access
PDF file
RMRegine Mugeni
Regine Mugeni
CRCharles Ruranga
Charles Ruranga
EMElias Mutezimana
Elias Mutezimana
ANAurore Nishimwe
Aurore Nishimwe
JNJoseph Nzabanita
Joseph Nzabanita
MTMarc Twagirumukiza
Marc Twagirumukiza
Objective To assess the level of compliance with COVID-19 preventive measures and compliance-associated factors in the Rwanda community. Design Cross-sectional study. Settings Country-wide community survey in Rwanda. Participants 4763 participants were randomly sampled following the sampling frame used for the recent Rwanda Demographic Health Survey. Participants were aged between 22 years and 94 years. Outcomes The participants’ compliance with three preventive measures (wearing a face mask, washing hands and social distancing) was the main outcome. Methods From 14 February 2022 to 27 February 2022, a cross-sectional survey using telephone calls was conducted. Study questionnaires included different questions such as participants’ demographics and compliance with COVID-19 preventives measures. Verbal consent was obtained from each participant. The compliance on three main preventive measures (wearing a mask, washing hands and social distancing) were the main outcomes. Univariate and multivariable logistic regression analyses were performed to evaluate factors associated with compliance (age, gender, level of education, socioeconomic status). Results Compliance with the three primary preventive measures (washing hands 98%, wearing a mask 97% and observing social distance 98%) was at a rate of 95%. The respondents’ mean age was 46±11 SD (range 22–98) years. In addition, 69% were female and 86% had attended primary education. Bivariate and regression analyses indicated a significant association among the three primary preventive measures (p<0.05). The results showed factors associated significantly between the different models (p<0.05): proper mask use and social distancing in the hand washing model; hand washing, social distancing, avoiding handshakes and not attending gatherings in the proper mask use model; hand washing and avoiding handshakes in the social distancing model. Conclusion Compliance with the three key preventive measures against COVID-19 was high in the Rwandan community and these measures were interdependent. Therefore, the importance of all three measures should be emphasised for effective disease control.

1 June 2019 in Diabetes
Verified
Journal Article
Closed access
SBSara M. Briker
Sara M. Briker
MHMargrethe Horlyck-Romanovsky
Margrethe Horlyck-Romanovsky
JAJessica Y. Aduwo
Jessica Y. Aduwo
RMRegine Mugeni
Regine Mugeni
CDChristopher Dubose
Christopher Dubose
ASAnne Sumner
Anne Sumner
As both diabetes (DM) and prediabetes (preDM) reach epidemic proportions in sub-Saharan Africa, there is growing need for reliable diagnostic tests. Although the OGTT is time-consuming, it is unaffected by hemoglobinopathies which are common in Africa and interfere with other methods of detection. However, the reproducibility of the OGTT in Africans is unknown. Therefore, our goal was to perform duplicate OGTTs in Africans and determine if the diagnosis made at the first OGTT was confirmed by the second. One-hundred and five African-born blacks (64% male (67/105), age 39±11y (mean±SD), BMI 27.4±4.5 kg/m2) living in the Washington, DC area had two OGTTs performed 11±7 days apart. Glucose tolerance status was defined by glucose criteria for the OGTT. κ-statistic was used to assess reproducibility (slight: 0.00 to 0.20; fair: 0.21 to 0.40; moderate: 0.41 to 0.60; substantial: 0.61 to 0.80, excellent: 0.81 to 1.0). At OGTT-1, DM, preDM and normal glucose tolerance (NGT) occurred in 23% (24/105), 26% (27/105) and 51% (54/105), resp. At OGTT-2, DM, preDM and NGT occurred in 19% (20/105), 26% (27/105) and 55% (58/105) resp. Reproducibility for the diagnosis of DM was excellent (κ=0.88). No one transitioned from DM to NGT. Further, all participants with DM at OGTT-2 had also been diagnosed with DM at OGTT-1. In contrast, reproducibility for the diagnosis of preDM was only moderate (κ=0.48). Between OGTT-1 and OGTT-2, 10% (11/105) of people transitioned from preDM to NGT; and 7% (7/105) transitioned from NGT to preDM. However, 78% (14/18) of the people who transitioned between NGT and preDM had fasting glucose levels between 90 and 99 mg/dL. Overall, as duplicate OGTTs provided highly reproducible results for the diagnosis of DM, detection of DM by a single OGTT should trigger health care consideration. Diagnosis of preDM was not consistent, but fasting glucose between 90 mg/dL and 99 mg/dL suggests that transition from NGT to preDM is likely. Disclosure S.M. Briker: None. M.F. Horlyck-Romanovsky: None. J.Y. Aduwo: None. R. Mugeni: None. C. DuBose: None. L. Mabundo: None. S.T. Chung: None. J. Ha: None. A. Sherman: None. A.E. Sumner: None.

1 June 2019 in Diabetes
Verified
Journal Article
Closed access
SBSara M. Briker
Sara M. Briker
MHMargrethe Horlyck-Romanovsky
Margrethe Horlyck-Romanovsky
JAJessica Y. Aduwo
Jessica Y. Aduwo
RMRegine Mugeni
Regine Mugeni
CDChristopher Dubose
Christopher Dubose
ASAnne Sumner
Anne Sumner
A1C is easier to perform than an OGTT, but A1C has a lower rate of detection of diabetes (DM) and prediabetes (preDM). Underperformance of A1C in the detection of hyperglycemia may be magnified in Africans. Three single gene mutations common in Africa, specifically sickle cell trait (SCT), hemoglobin C (HbC) trait and glucose-6-phosphate dehydrogenase (G6PD) deficiency may lead to artefactually low A1C levels. Our goals were: (1) compare DM and preDM prevalence diagnosed by either A1C or OGTT; (2) evaluate whether SCT, HbC trait or G6PD deficiency impact A1C levels. Participants were 421 African-born blacks living in America (male: 66% (276/421), age: 38±10y (mean±SD)). A1C and OGTT were done with repeat studies done in 105 participants 11±7 days later. Diagnosis of DM and preDM required meeting either A1C criteria or glucose guidelines for the OGTT. G6PD activity was assayed in 50 consecutively enrolled participants. DM prevalence was 8% (32/421). Detection of DM by A1C-alone, A1C and OGTT and OGTT-alone were: 16% (5/32), 16% (5/32), and 68% (22/32), respectively. PreDM prevalence was 42% (177/421) with detection rates by A1C-alone, A1C and OGTT and OGTT-alone: 28% (49/177), 30% (53/177) and 42% (75/177), respectively. Repeat testing gave similar results. Among people with DM, 40% (13/32) had either SCT or HbC trait. A1C failed in 77% (10/13) of people with both DM and either SCT or HbC trait. Overall, A1C was 3 times more likely to fail in the detection of DM if either SCT or HbC trait was present (Odds Ratio 3.5 (95% CI: 1.7, 7.5), P<0.01). Prevalence of G6PD deficiency was 16% (8/50). At similar levels of glycemia, A1C levels were lower with G6PD deficiency (4.3±0.1 vs. 5.5±1.0%, P<0.01). Working with African-born blacks living in America, we found that if only A1C was performed, 68% with DM and 42% with preDM would be undiagnosed. SCT, HbC trait and G6PD deficiency contribute to inappropriately low A1C levels and missed opportunity to detect hyperglycemia. Disclosure: S.M. Briker: None. M.F. Horlyck-Romanovsky: None. J.Y. Aduwo: None. R. Mugeni: None. C. DuBose: None. L. Mabundo: None. S.T. Chung: None. J. Ha: None. A. Sherman: None. A.E. Sumner: None.